After participating in this educational activity, attendees should be able to:
1. Describe immunogneic determinants in beta-lactam allergy and the concept of cross reactivity between them.
2. Discuss the risks associated with the use of the second line antibiotics in patients with reported beta-lactam allergy
3. Decide on a safe beta-lactam antibiotic based on patient's allergy profile, given a patient case.
Mehrnaz Sadrolashrafi, PharmD
PGY1 Pharmacy Resident
Baystate Medical Center
None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.
- 1.00 ACPE Contact Hours